The Martinique Principles in Radioiodine Therapy of Differentiated Thyroid Cancer

Гелиашвили, Т. М.; Крылов, В В; Гарбузов, П. И.; Родичев, А А; Shurinov, A. Yu.; Kochetova, T. Yu.; Petrosyan, K. M.; Бородавина, Е. В.

doi:10.22328/2079-5343-2020-11-3-20-24

Cited by 2 publications

(1 citation statement)

References 6 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Martinique hosted in 2018 and 2020 international consensus conferences, gathering European, American and Caribbean expertise in order to produce up-to-date guidelines, registered as “The Martinique Principles”, regarding interdisciplinary cooperation, therapy decision and use of radioiodine in thyroid cancer. The local impact of those new guidelines needs to be assessed in the future [ 11 ].…”

Section: Discussionmentioning

confidence: 99%

Overall survival of patients with thyroid cancer in Martinique (2008–2018)

et al. 2023

View full text Add to dashboard Cite

Background Thyroid cancer (TC) overall survival at 5 years was estimated at 97% in mainland France over 2010–2015. Its prognosis is known to be affected by patient age, tumor histology, size, and extension. This study aims to describe overall survival of thyroid cancer patients diagnosed between 2008 and 2018 in Martinique. Methods We included in this retrospective analytical study all patients who were diagnosed with thyroid cancer. An overall survival analysis at 1, 3 and 5 years of thyroid cancer patients diagnosed in Martinique from 2008 to 2018 was conducted. Prognostic factors associated with survival have been identified. Stage at diagnosis and patterns of care among thyroid cancer patients were analyzed. Results A total of 323 thyroid cancer patients were registered between 2008 and 2018. Papillary carcinomas represented 83% of diagnoses. Local stage or locally advanced invasion was found in 264 (88%) patients. 221 Multidisciplinary Teams reports files were reviewed. The overall survival observed in this population is 97% [93–99] at 1 year, 93% [88–97] at 3 years and 91% [85–95] at 5 years. Anaplastic, poorly differentiated and medullar tumors had lower survival rates at 5 years (39% [13–65]) compared to papillary tumors (93% [89–96]). We found that metastatic stage at diagnosis (HR = 3.1[1.3–7.6]; p = 0.01) and tumor size > 3 cm (HR = 2.7 [1.1–6.3]) were independent prognostic factors for OS in our population. Conclusions The survival rates of thyroid cancer in Martinique are comparable to those observed in France.

show abstract

Section: Discussionmentioning

confidence: 99%

Overall survival of patients with thyroid cancer in Martinique (2008–2018)

et al. 2023

View full text Add to dashboard Cite

show abstract

Comments to the Section on Radioiodine Therapy for Differentiated Thyroid Cancer in Children of the European Thyroid Association Guidelines 2022

Гелиашвили¹,

Долгушин²,

Polyakov³

2023

jour

Self Cite

View full text Add to dashboard Cite

Children are not “miniature” adults! Most experts around the world recognize the differences between adult and pediatric thyroid cancer and emphasize the need for specific guidelines for the pediatric population. The American Thyroid Association (ATA) first developed separate Guidelines for the Treatment of Pediatric Thyroid Nodules and Carcinoma (hereafter, ATA Guidelines) in 2015 [1], which has not been revised to date. In September 2022, the European Thyroid Association (ETA) published its Guideline on the Management of Pediatric Thyroid Nodules and Differentiated Thyroid Carcinoma (hereafter, ETA Guidelines) [2]. The aim of our article, in anticipation of the revision of Russian clinical guidelines for the treatment of pediatric thyroid cancer, is to inform specialists in the field of radioiodine therapy (RIT) with the key recommendations of the ETA.

show abstract

The Martinique Principles in Radioiodine Therapy of Differentiated Thyroid Cancer

Cited by 2 publications

References 6 publications

Overall survival of patients with thyroid cancer in Martinique (2008–2018)

Overall survival of patients with thyroid cancer in Martinique (2008–2018)

Comments to the Section on Radioiodine Therapy for Differentiated Thyroid Cancer in Children of the European Thyroid Association Guidelines 2022

Contact Info

Product

Resources

About